Articles dans des revues avec comité de lecture (179)
  1. 59. Marot, A., Henrion, J., Knebel, J. F., Moreno, C., & Deltenre, P. (2017). Alcoholic liver disease confers a worse prognosis than HCV infection and nonalcoholic fatty liver disease among patients with cirrhosis: An observational study. PloS one, 12(10), e0186715. doi:10.1371/journal.pone.0186715
  2. 60. Litwak, S. A., Pang, L., Galic, S., Igoillo Esteve, M., Stanley, W. J., Turatsinze, J. V., Loh, K., Thomas, H. H., Sharma, A., Trepo, E., Moreno, C., Gough, D. J., Eizirik, D., de Haan, J. B., & Gurzov, E. N. (2017). JNK Activation of BIM Promotes Hepatic Oxidative Stress, Steatosis and Insulin Resistance in Obesity. Diabetes (New York, N.Y.). doi:10.2337/db17-0348
  3. 61. Bielen, R., De Galocsy, C., Janssens, F., Cool, M. M., Van Overbeke, L., van Steenkiste, C., D'Heygere, F., Cools, W., Nevens, F., Robaeys, G., Moreno, C., Van Vlierberghe, H., Bourgeois, S., Mulkay, J.-P., Vanwolleghem, T., Verlinden, W., Brixko, C., & Decaestecker, J. (2017). Belgian experience with direct acting antivirals in people who inject drugs. Drug and alcohol dependence, 177, 214-220. doi:10.1016/j.drugalcdep.2017.04.003
  4. 62. Marot, A., Trepo, E., Doerig, C., Schoepfer, A. A., Moreno, C., & Deltenre, P. (2017). Liver stiffness and platelet count for identifying patients with compensated liver disease at low risk of variceal bleeding. Liver international, 37(5), 707-716. doi:10.1111/liv.13318
  5. 63. Sulkowski, M., Matthews, G., Molina, J.-M., Moreno, C., Pineda, J. A., Pulido, F., Rivero, A., Rockstroh, J., Hernandez, D., McPhee, F., Eley, T., Fessel, W. J., Liu, Z., Mendez, P., Hughes, E., Noviello, S., Ackerman, P., Lazzarin, A., Berenguer, J., Zakharova, N., Cheinquer, H., Côté, P., Dieterich, D., & Gadano, A. (2017). Efficacy and safety of daclatasvir plus pegylated-interferon alfa 2a and ribavirin in previously untreated HCV subjects coinfected with HIV and HCV genotype-1: a Phase III, open-label study. Hepatology International, 11(2), 188-198. doi:10.1007/s12072-017-9788-z
  6. 64. Blach, S., & Moreno, C. (2017). Global prevalence and genotype distribution of hepatitis C virus infection in 2015: A modelling study. The Lancet Gastroenterology and Hepatology, 2(3), 161-176. doi:10.1016/S2468-1253(16)30181-9
  7. 65. Bourgeois, S., Francque, S., Vijgen, L., Kakuda, T. T., Hoeben, E., Luo, D., Vandebosch, A., Jacquemyn, B., Van Remoortere, P., Verloes, R., Van Vlierberghe, H., Moreno, C., Orlent, H., Nevens, F., Arasteh, K., Horsmans, Y., Schattenberg, J. M., & Buggisch, P. (2017). Efficacy, safety and pharmacokinetics of simeprevir and TMC647055/ritonavir with or without ribavirin and JNJ-56914845 in HCV genotype 1 infection. BMC gastroenterology, 17(1), 26. doi:10.1186/s12876-017-0580-2
  8. 66. Stickel, F., Moreno, C., Hampe, J., & Morgan, M. Y. (2017). The genetics of alcohol dependence and alcohol-related liver disease. Journal of hepatology, 66(1), 195-211. doi:10.1016/j.jhep.2016.08.011
  9. 67. Asselah, T., Lenz, O., Van Dooren, G., Nalpas, C., Lonjon-Domanec, I., Schlag, M., Buti, M., Moreno, C., Sarrazin, C., Gschwantler, M., Foster, G. G., Craxí, A., Buggisch, P., Sanai, F., & Bicer, C. (2017). Efficacy of a 12-week simeprevir plus peginterferon/ribavirin (PR) regimen in treatment-naïve patients with hepatitis C virus (HCV) genotype 4 (GT4) infection and mild-to-moderate fibrosis displaying early on-treatment virologic response. PloS one, 12(1), e0168713. doi:10.1371/journal.pone.0168713
  10. 68. Degré, D., Vanwolleghem, T., Dastis, S. N., Gustot, T., Geerts, A., van Steenkiste, C., De Galocsy, C., Lepida, A., Orlent, H., Moreno, C., Serste, T., Lasser, L., Delwaide, J., Starkel, P., Laleman, W., Langlet, P., Reynaert, H., & Bourgeois, S. (2017). Sofosbuvir in combination with simeprevir +/- ribavirin in genotype 4 hepatitis C patients with advanced fibrosis or cirrhosis: A real-world experience from Belgium. PloS one, 12(1), e0170933. doi:10.1371/journal.pone.0170933
  11. 69. Karakike, E., Moreno, C., & Gustot, T. (2017). Infections in severe alcoholic hepatitis. Annals of Gastroenterology, 30(2), 152-160. doi:10.20524/aog.2016.0101
  12. 70. Bruyneel, M., Serste, T., Libert, W., Van Den Broecke, S., Ameye, L., Dachy, B., Mulkay, J.-P., Moreno, C., & Gustot, T. (2017). Improvement of sleep architecture parameters in cirrhotic patients with recurrent hepatic encephalopathy with the use of rifaximin. European journal of gastroenterology & hepatology, 29(3), 302-308. doi:10.1097/MEG.0000000000000786
    13. << Précédent 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 Suivant >>